Dr. Parameswaran Nair is the Frederick E. Hargreave Teva Innovation Chair in Airway Diseases and Professor of Medicine in the Division of Respirology at McMaster University in Hamilton, Ontario, providing tertiary care to patients with severe asthma and other complex airway diseases. He directs a patient-centred translational research program centred on charactering bronchitis using sputum biomarkers and targeted therapy. The research program has been recognized by a Canada Research Chair, the American Thoracic Society’s Ann Woolcock Award, the Asthma Society of Canada’s Bastable Potts Award, and Fellowships of the European Respiratory Society and the Collegium Internationale Allergologicum, and has contributed to over 270 peer-reviewed publications (h-index 57, >15,500 citations).